Clinical Trial Update: Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoE [Phase 2]

View source ↗

Summary

Phase 2 trial compares dupilumab to topical corticosteroid in stenotic eosinophilic esophagitis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• Dupilumab (dupilumab)
• Topical corticosteroid (corticosteroid)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Eosinophilic Esophagitis | Phase 2 | Status: RECRUITING